Supannikar Tawinwung

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHybrid and electric vehicles and powertrainsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 11, 2025
A Bidirectional EF1 Promoter System for Armoring CD19 CAR-T Cells with Secreted Anti-PD1 Antibodies.

Asmita Khaniya, Nattarika Khuisangeam, Supannikar Tawinwung

|Jan 25, 2025
Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study.

Thananya Inthanachai, Chatikorn Boonkrai, Tanapati Phakham

|Oct 25, 2023
Effects of Cannabidiol on the Functions of Chimeric Antigen Receptor T Cells in Hematologic Malignancies.

Natthida Chantarat, Kristine Cate S Pe, Koramit Suppipat

|Dec 02, 2022
An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment.

Nattarika Khuisangeam, Sirirut Jewmoung, Rattapoom Thaiwong

|Aug 12, 2022
Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.

Kristine Cate S Pe, Rattana Saetung, Varalee Yodsurang

Pageof 1